Literature DB >> 31395752

A 5-year evaluation of the emergency contraception enhanced community pharmacy service provided in Wales.

Efi Mantzourani1, Karen Hodson2, Andrew Evans3, Sarah Alzetani2, Rebecca Hayward2, Rhian Deslandes2, Mary Louise Hughes2, Gareth Holyfield4, Cheryl Way5.   

Abstract

BACKGROUND: Access to emergency contraception (EC) has been a core component of attempts to address high teenage pregnancy rates in Wales. A national service was commissioned in 2011, allowing supply of EC free of charge from community pharmacies (CPs). This study investigated 5 years of the EC service, to describe its use and investigate changes in the pattern of use over time.
METHODS: Secondary analyses of data from all National Health Service funded CP EC consultations in Wales between 1 August 2012 and 31 July 2017 (n=181 359). Data comprised standardised clinical and demographic information, in the form of predefined service user responses, submitted for reimbursement by CPs.
RESULTS: Overall service provision remained relatively consistent over the study period, with women aged between 13 and 59 years accessing the service. An association was observed between the time since unprotected sexual intercourse and the day on which the service was accessed (Χ2(18)=16 292.327, p<0.001). Almost half (47.9%) of requests were because no contraception had been used, with a strong and positive association for teenagers and women aged 40+ years. A statistically significant and increasing percentage of consultations were accompanied by further sexual health advice (r=0.7, p<0.01).
CONCLUSIONS: Access to EC through CPs is contributing to reducing teenage conceptions and termination rates. However, action is needed to increase contraception use in all age groups. Reduced availability of CP services on Sundays is a barrier to timely EC access. Findings support an expanded role for community pharmacists in provision of regular contraception. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  community pharmacy service; emergency contraception; oral contraception; secondary analysis; service delivery; sex education

Year:  2019        PMID: 31395752     DOI: 10.1136/bmjsrh-2018-200236

Source DB:  PubMed          Journal:  BMJ Sex Reprod Health        ISSN: 2515-1991


  5 in total

1.  Emergency Oral Contraceptive Consultations in Pharmacies in a Rural Setting: An Epidemiological Analysis.

Authors:  Emma Pearce; Kate Jolly
Journal:  J Pharm Pract       Date:  2020-09-29

2.  Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.

Authors:  Sharon T Cameron; Anna Glasier; Lisa McDaid; Andrew Radley; Paula Baraitser; Judith Stephenson; Richard Gilson; Claire Battison; Kathleen Cowle; Mark Forrest; Beatriz Goulao; Anne Johnstone; Alessandra Morelli; Susan Patterson; Alison McDonald; Thenmalar Vadiveloo; John Norrie
Journal:  Lancet       Date:  2020-11-14       Impact factor: 202.731

3.  Impact of a pay-for-performance scheme for long-acting reversible contraceptive (LARC) advice on contraceptive uptake and abortion in British primary care: An interrupted time series study.

Authors:  Richard Ma; Elizabeth Cecil; Alex Bottle; Rebecca French; Sonia Saxena
Journal:  PLoS Med       Date:  2020-09-14       Impact factor: 11.069

4.  Utilisation of pharmacy-based sexual and reproductive health services: a quantitative retrospective study.

Authors:  Julia Gauly; Helen Atherton; Peter K Kimani; Jonathan Ross
Journal:  Sex Transm Infect       Date:  2020-08-15       Impact factor: 3.519

5.  Emergency contraception from the pharmacy 20 years on: a mystery shopper study.

Authors:  Anna Glasier; Paula Baraitser; Lisa McDaid; John Norrie; Andrew Radley; Judith M Stephenson; Claire Battison; Richard Gilson; Sharon Cameron
Journal:  BMJ Sex Reprod Health       Date:  2020-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.